Asthma/COPD:

Indications for INCRUSE ELLIPTA:

Maintenance treatment of COPD.

Adult Dosage:

Take at same time every day. 1 inhalation every 24hrs.

Children Dosage:

Not established.

INCRUSE ELLIPTA Contraindications:

Severe hypersensitivity to milk proteins.

INCRUSE ELLIPTA Warnings/Precautions:

Not indicated for relief of acute bronchospasm. Do not initiate in rapidly or acutely deteriorating COPD. Do not exceed recommended dose. Reevaluate periodically. Prescribe a short-acting, inhaled β2-agonist for acute symptoms; monitor for increased need. Discontinue if paradoxical bronchospasm (use alternatives) or hypersensitivity reactions occur. Narrow-angle glaucoma. Urinary retention. Prostatic hyperplasia. Bladder-neck obstruction. Severe hepatic impairment. Pregnancy. Nursing mothers.

INCRUSE ELLIPTA Classification:

Anticholinergic.

INCRUSE ELLIPTA Interactions:

Additive effects with concomitant other anticholinergic-containing drugs; avoid.

Adverse Reactions:

Nasopharyngitis, URTI, cough, arthralgia; visual disturbances, paradoxical bronchospasm.

Generic Drug Availability:

NO

How Supplied:

Dry pwd inhaler—30 doses

Pricing for INCRUSE ELLIPTA

30 blisters of 62.5mcg inhaler (Qty: 1)
Appx. price $360
GoodRx